Rankings
▼
Calendar
JAZZ Q2 2016 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena
JAZZ
Jazz Pharmaceuticals plc
$11B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$381M
Gross Profit
$357M
93.7% margin
Operating Income
$169M
44.3% margin
Net Income
$111M
29.2% margin
EPS (Diluted)
$1.85
QoQ Revenue Growth
+13.4%
Cash Flow
Operating Cash Flow
$130M
Free Cash Flow
-$22M
Stock-Based Comp.
$25M
Balance Sheet
Total Assets
$3.4B
Total Liabilities
$1.8B
Stockholders' Equity
$1.7B
Cash & Equivalents
$868M
Revenue Segments
Defitelio
$33M
100%
Geographic Segments
UNITED STATES
$346M
91%
Europe
$29M
8%
Other Countries
$7M
2%
← FY 2016
All Quarters
Q3 2016 →